New symmetry-breaking method opens way for bioactive compounds

February 22, 2018, Ecole Polytechnique Federale de Lausanne
A demonstration of molecular chirality using 3-D atomic models in the lab. Credit: J. Waser/EPFL

Many chemical molecules can exist in nature together with their mirror counterparts; like hands, two compounds can be made up of the same atoms in the same overall structure but in opposite orientations, i.e. left-handed and right-handed. This phenomenon of symmetry is called "chirality", and can give mirror counterparts ("enantiomers") entirely different chemical properties. A famous and tragic example of chirality is thalidomide, which was originally sold as a mixture of both enantiomers. The problem was that one was a harmless sedative and the other highly toxic to fetuses, resulting in disturbing congenital deformities.

So today it has become imperative to synthesize compounds with what is known as high "optical purity", which is a measurement of chiral purity: the degree to which a sample contains one in greater amounts than the other. But because enantiomers have very small structural differences and identical stability, synthesizing one over the other is a very challenging task.

One way to do this is what chemists call "desymmetrization" of a non-chiral compound that is similar to the target molecule. This involves modifying a molecule so that it loses the symmetry elements that prevented it to be chiral.

Researchers at Jérôme Waser's Laboratory of Catalysis and Organic Synthesis at EPFL have now developed a new desymmetrization strategy to access chiral building blocks containing urea sub-structures. Urea derivatives are important components of biomolecules such as biotin (vitamin B7) or bioactive natural products, such as the anticancer agelastatin A.

The researchers made two crucial innovations. First, they designed a non-chiral cyclopropane (three-membered carbon ring) precursor. This molecule offers enhanced reactivity and is ideal for reactions under mild conditions.

New symmetry-breaking method opens way for bioactive compounds
The three main approaches to accessing one enantiomer selectively: 1) Separate a mixture of the two enantiomers (resolution), wasting one of the enantiomers. 2) Synthesize selectively only one of the two enantiomers. 3) Use a "desymmetrization" of a non-chiral compound similar to the target. This is used less often, but it is particularly elegant as it can reveal chirality from an already relatively complex precursor by breaking the symmetry in only one simple transformation. Credit: J. Waser/EPFL

Second, the researchers engineered a new copper catalyst that can form an enantiomer of the desired product with high selectivity. The copper center binds and activates the cyclopropane precursor, causing its bonds to break. The precursor is then attacked by an indole, a molecule very important as structural element of bioactive compounds. As a result, the precursor loses its symmetry - and therefore becomes chiral - and can be used to selectively make the desired enantiomer.

The work is an important breakthrough, as desymmetrization has never been used to access chiral ureas from cyclopropanes before. "New building blocks can be now easily accessed as pure enantiomers, and can be tested for bioactivity or used to synthesize more complex chiral ," says Jérôme Waser. "Moreover, the new catalyst we have designed certainly will be useful for other applications in synthetic chemistry."

New symmetry-breaking method opens way for bioactive compounds
Ureas: important building blocks of bioactive molecules. Credit: J. Waser/EPFL

Explore further: The multitasking catalyst

More information: Daniele Perrotta et al, Lewis Acid Catalyzed Enantioselective Desymmetrization of Donor-Acceptor Meso-Diaminocyclopropanes, Angewandte Chemie International Edition (2018). DOI: 10.1002/anie.201800494

Related Stories

The multitasking catalyst

January 25, 2018

Professor Takashi Ooi and his team of researchers from Nagoya University, Japan, have designed a catalyst that performs two tasks during the course of the reaction.

Taming the molecule's Dr. Jekyll and Mr. Hyde

June 14, 2011

Many organic molecules are non-superimposable with their mirror image. The two forms of such a molecule are called enantiomers and can have different properties in biological systems. The problem is to control which enantiomer ...

Chiral crabs

September 22, 2017

Sander Wezenberg, and PhD students Thomas van Leeuwen and Kaja Sitkowska, from the University of Groningen in the Netherlands, spoke to us about their work in chirality and molecular motors, and the seaside scene on the cover ...

New method to determine molecule chirality

February 20, 2018

Identifying right-handed and left-handed molecules is a crucial step for many applications in chemistry and pharmaceutics. An international research team (CELIA-CNRS/INRS/Berlin Max Born Institute/SOLEIL) has now presented ...

Recommended for you

3-D culturing hepatocytes on a liver-on-a-chip device

January 17, 2019

Liver-on-a-chip cell culture devices are attractive biomimetic models in drug discovery, toxicology and tissue engineering research. To maintain specific liver cell functions on a chip in the lab, adequate cell types and ...

This computer program makes pharma patents airtight

January 17, 2019

Routes to making life-saving medications and other pharmaceutical compounds are among the most carefully protected trade secrets in global industry. Building on recent work programming computers to identify synthetic pathways ...

Cultivating 4-D tissues—the self-curving cornea

January 17, 2019

Scientists at Newcastle University have developed a biological system which lets cells form a desired shape by moulding their surrounding material—in the first instance creating a self-curving cornea.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.